-+ 0.00%
-+ 0.00%
-+ 0.00%

*SAB Biotherapeutics: Operational Runway Through 2028 to Support SAFEGUARD Study, PRISE-hATG Study and pre-Comml Activities >SABS

Dow Jones·08/06/2026 11:30:00

Please log in to view news